Organon Continues Building Women’s Health Portfolio With Forendo Buyout

The Finnish company’s endometriosis candidate could offer a better safety profile and be the first drug to address disease progression, Organon claims. Q3 revenues declined slightly due to pandemic, generic competition.

Women's Health

You’ll Save On Water And Toilet Paper With These Bidet Attachments

Your butt’s in for a treat.

Read More
Women's Health

Howell Foundation diversifies and expands for broader impact on women’s health research

Spotlight: Operating under the phrase “Grow and prosper,” the Doris A.

Read More
Women's Health

Irving-based Biote CEO advocating for more women’s health research

Irving-based Biote is a hormone optimization company that offers patients personalized hormone therapy and clinical-grade nutraceuticals.

Read More